News - Bronchial Thermoplasty
2012-03-27 02:27:27
NATICK, Mass., March 27, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the first published technology assessment in support of the safety, efficacy and long-term
Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
2012-01-04 06:30:00
"It supports what we have confirmed through our clinical trials: bronchial thermoplasty offers a new advancement in the treatment of patients with severe asthma who are not well controlled despite taking recommended doses of asthma medications. This decision also sets an important precedent for health care payers throughout the United States."
2010-09-08 08:57:05
Researchers say as many as 50 percent treatment-resistant asthma cases in kids are misdiagnosed.
